INS and diabetes mellitus: Since its beginning in the United States in 2013, this movement has globally advanced diabetes technologies, particularly in open-source hybrid closed-loop systems and improved access to CGM data.18, -20 Hybrid closed-loop systems were commercialized in 2016 but faced delayed accessibility in Norway and other countries, leading to reliance on DIY solutions.21,22 A similar situation is occurring in the 2020s with automated insulin delivery (AID) systems, reflecting hybrid closed-loop systems‘ initial challenges.23